BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18619432)

  • 1. Specific, rapid, and sensitive enzymatic measurement of sphingomyelin, phosphatidylcholine and lysophosphatidylcholine in serum and lipid extracts.
    Hidaka H; Yamauchi K; Ohta H; Akamatsu T; Honda T; Katsuyama T
    Clin Biochem; 2008 Oct; 41(14-15):1211-7. PubMed ID: 18619432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients.
    Ohkawa R; Kishimoto T; Kurano M; Dohi T; Miyauchi K; Daida H; Nagasaki M; Uno K; Hayashi N; Sakai N; Matsuyama N; Nojiri T; Nakamura K; Okubo S; Yokota H; Ikeda H; Yatomi Y
    Clin Biochem; 2012 Nov; 45(16-17):1463-70. PubMed ID: 22820437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme combination assay for serum sphingomyelin: Improved specificity through avoiding the interference with lysophosphatidylcholine.
    Kimura T; Kuwata H; Miyauchi K; Katayama Y; Kayahara N; Sugiuchi H; Matsushima K; Kondo Y; Ishitsuka Y; Irikura M; Irie T
    Anal Biochem; 2016 Apr; 498():29-36. PubMed ID: 26792376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine.
    Hojjati MR; Jiang XC
    J Lipid Res; 2006 Mar; 47(3):673-6. PubMed ID: 16371647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis.
    Kulschar R; Engelmann B; Bräutigam C; Duhm J; Thiery J; Richter WO
    Eur J Clin Invest; 1995 Apr; 25(4):258-65. PubMed ID: 7601201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The phospholipid spectrum of the blood serum in patients with chronic non-specific pulmonary diseases during rehabilitation treatment].
    Ivanov EM; Novgorodtseva TP; Endakova EA; Svetashev VI
    Ter Arkh; 1989; 61(3):94-7. PubMed ID: 2741128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of phosphatidylcholine, lysophosphatidylcholine, and sphingomyelin in human serum.
    Fleming JK; Gadsden RH
    Clin Biochem; 1987 Aug; 20(4):249-56. PubMed ID: 3690827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shape changes and vesicle fission of giant unilamellar vesicles of liquid-ordered phase membrane induced by lysophosphatidylcholine.
    Tanaka T; Sano R; Yamashita Y; Yamazaki M
    Langmuir; 2004 Oct; 20(22):9526-34. PubMed ID: 15491182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.
    Yang P; Subbaiah PV
    Biochim Biophys Acta; 2015 Oct; 1851(10):1327-36. PubMed ID: 26193433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of the spleen to the lipid metabolism in plasma and red cells. On hereditary spherocytosis and hereditary high red cell membrane phosphatidylcholine hemolytic anemia].
    Sugihara T; Otsuka A; Yawata Y
    Rinsho Ketsueki; 1989 Aug; 30(8):1248-55. PubMed ID: 2601042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
    Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific and sensitive enzymatic measurement of sphingomyelin in cultured cells.
    Morita SY; Soda K; Teraoka R; Kitagawa S; Terada T
    Chem Phys Lipids; 2012 Jul; 165(5):571-6. PubMed ID: 22727956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major plasma lipids and fatty acids in four HDL mammals.
    Maldonado EN; Casanave EB; Aveldaño MI
    Comp Biochem Physiol A Mol Integr Physiol; 2002 Jun; 132(2):297-303. PubMed ID: 12020646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol transfer protein beta displays minimal sphingomyelin transfer activity and is not required for biosynthesis and trafficking of sphingomyelin.
    Ségui B; Allen-Baume V; Cockcroft S
    Biochem J; 2002 Aug; 366(Pt 1):23-34. PubMed ID: 12023904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H NMR at 800 MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins.
    Soininen P; Oörni K; Maaheimo H; Laatikainen R; Kovanen PT; Kaski K; Ala-Korpela M
    Biochem Biophys Res Commun; 2007 Aug; 360(1):290-4. PubMed ID: 17592725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. I. Increased phosphatidylcholine and reduced sphingomyelin in patients with elevated levels of triacylglycerol-rich lipoproteins.
    Engelmann B; Streich S; Schönthier UM; Richter WO; Duhm J
    Biochim Biophys Acta; 1992 Nov; 1165(1):32-7. PubMed ID: 1420345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.
    Engelmann B; Kögl C; Kulschar R; Schaipp B
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):781-9. PubMed ID: 8645158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive method for the determination of pulmonary surfactant phospholipid/sphingomyelin ratio in human amniotic fluids for the diagnosis of respiratory distress syndrome by thin-layer chromatography-immunostaining.
    Iwamori M; Hirota K; Utsuki T; Momoeda K; Ono K; Tsuchida Y; Okumura K; Hanaoka K
    Anal Biochem; 1996 Jun; 238(1):29-33. PubMed ID: 8660581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lipids in the diagnosis of severity of acute viral hepatitis A].
    Makarov VK; Chaĭnikova EA
    Klin Lab Diagn; 2006 Oct; (10):18-9. PubMed ID: 17144540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS.
    Stübiger G; Aldover-Macasaet E; Bicker W; Sobal G; Willfort-Ehringer A; Pock K; Bochkov V; Widhalm K; Belgacem O
    Atherosclerosis; 2012 Sep; 224(1):177-86. PubMed ID: 22795978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.